Literature DB >> 1908528

The roles of extracorporeal shock wave lithotripsy and percutaneous nephrostolithotomy in the management of pyelocaliceal diverticula.

J A Jones1, J E Lingeman, C P Steidle.   

Abstract

Various combinations of extracorporeal shock wave lithotripsy (ESWL*) and percutaneous nephrostolithotomy were used in the treatment of 40 stone-containing caliceal diverticula in 39 patients (16 men and 23 women). Only 1 of 26 patients (4%) treated with ESWL as a single modality became stone-free, although 9 (36%) became asymptomatic. Ten patients undergoing ESWL primarily eventually required percutaneous nephrostolithotomy due to persistence of symptoms and all became stone-free. A total of 14 patients underwent a percutaneous approach as a single modality, and the diverticula in 13 of these patients became stone-free, although 2 patients did have residual parenchymal fragments. Therefore, 21 of 24 patients (87.5%) became completely free of stones using the percutaneous approach. All patients managed with percutaneous nephrostolithotomy became free of symptoms. The complex nature of access during percutaneous nephrostolithotomy favors a 1-stage approach with direct puncture into the stone-containing diverticulum. Simultaneous fulguration of the diverticulum at percutaneous nephrostolithotomy is favored, since all 17 patients in whom this technique was used had complete obliteration of the diverticulum on followup contrast studies. These data suggest that caliceal diverticula should be managed with percutaneous nephrostolithotomy, since ESWL monotherapy is unlikely to produce a stone-free or symptom-free status.

Entities:  

Mesh:

Year:  1991        PMID: 1908528     DOI: 10.1016/s0022-5347(17)37906-5

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

1.  The pathogenesis of calyceal diverticular calculi.

Authors:  Brian R Matlaga; Nicole L Miller; Colin Terry; Samuel C Kim; Ramsay L Kuo; Fredric L Coe; Andrew P Evan; James E Lingeman
Journal:  Urol Res       Date:  2007-02-02

2.  Difficulties with access in percutaneous renal surgery.

Authors:  Soroush Rais-Bahrami; Justin I Friedlander; Brian D Duty; Zeph Okeke; Arthur D Smith
Journal:  Ther Adv Urol       Date:  2011-04

3.  Retrograde intrarenal surgery in the management of symptomatic calyceal diverticular stones: a single center experience.

Authors:  Xiong Chen; Dongjie Li; Yuanqing Dai; Yao Bai; Qizhan Luo; Zhongwei Zhao; Hequn Chen; Xiaobo Zhang
Journal:  Urolithiasis       Date:  2015-07-03       Impact factor: 3.436

Review 4.  Calyceal diverticula: a comprehensive review.

Authors:  Nikhil Waingankar; Samih Hayek; Arthur D Smith; Zeph Okeke
Journal:  Rev Urol       Date:  2014

5.  Percutaneous endoscopic treatment for calyceal diverticular calculi.

Authors:  Akiou Okumura; Koich Murakami; Masashi Yoshida; Osamu Nagakawa; Hideki Fuse
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

Review 6.  Management of complex renal calculi.

Authors:  S A Holmes; H N Whitfield
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

7.  Percutaneous management of caliceal diverticuli.

Authors:  Amy E Krambeck; James E Lingeman
Journal:  J Endourol       Date:  2009-10       Impact factor: 2.942

8.  Management of calyceal diverticular calculi: a comparison of percutaneous nephrolithotomy and flexible ureterorenoscopy.

Authors:  Okan Bas; Ekrem Ozyuvali; Yasin Aydogmus; Nevzat Can Sener; Onur Dede; Serhat Ozgun; Fatih Hizli; Cagri Senocak; Omer Faruk Bozkurt; Halil Basar; Abdurrahim Imamoglu
Journal:  Urolithiasis       Date:  2014-09-24       Impact factor: 3.436

9.  Is retrograde flexible nephrolithotripsy feasible for calyceal diverticular stone?

Authors:  Bulent Erkurt; Murat Can Kiremit; Bulent Altay; Vahit Guzelburc; Mustafa Soytas; Firat Erdogan; Cem Cahit Barisik; Selami Albayrak
Journal:  Urolithiasis       Date:  2014-06-12       Impact factor: 3.436

10.  Percutaneous holmium laser fulguration of calyceal diverticula.

Authors:  Amjad Alwaal; Raed A Azhar; Sero Andonian
Journal:  Case Rep Urol       Date:  2012-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.